相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。miR-490 suppresses telomere maintenance program and associated hallmarks in glioblastoma
Omkar Suhas Vinchure et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Diagnostic and therapeutic evaluation of folate-targeted paclitaxel and vinorelbine encapsulating theranostic liposomes for non-small cell lung cancer
Merve Karpuz et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies
Liang Han et al.
ACTA PHARMACEUTICA SINICA B (2021)
Current and future nanoparticle vaccines for COVID-19
Mai N. Vu et al.
EBIOMEDICINE (2021)
Noncoding RNA therapeutics - challenges and potential solutions
Melanie Winkle et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
A Novel Screen for Expression Regulators of the Telomeric Protein TRF2 Identified Small Molecules That Impair TRF2 Dependent Immunosuppression and Tumor Growth
Mounir El Mai et al.
CANCERS (2021)
Recent Advances in Liposomal-Based Anti-Inflammatory Therapy
Carla M. A. van Alem et al.
PHARMACEUTICS (2021)
Shelterin complex gene: Prognosis and therapeutic vulnerability in cancer
Vikas Kumar Bhari et al.
BIOCHEMISTRY AND BIOPHYSICS REPORTS (2021)
In Vitro Biophysical and Biological Characterization of Lipid Nanoparticles Co-Encapsulating Oncosuppressors miR-199b-5p and miR-204-5p as Potentiators of Target Therapy in Metastatic Melanoma
Luigi Fattore et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Role of Alternative Lengthening of Telomeres Mechanism in Cancer: Translational and Therapeutic Implications
Marta Recagni et al.
CANCERS (2020)
Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer
Jun Sheng Wong et al.
NON-CODING RNA (2020)
Triple-negative breast cancer molecular subtyping and treatment progress
Li Yin et al.
BREAST CANCER RESEARCH (2020)
TRF2 positively regulates SULF2 expression increasing VEGF-A release and activity in tumor microenvironment
Pasquale Zizza et al.
NUCLEIC ACIDS RESEARCH (2019)
SFPQ and NONO suppress RNA:DNA-hybrid-related telomere instability
Eleonora Petti et al.
NATURE COMMUNICATIONS (2019)
Cancer cells induce immune escape via glycocalyx changes controlled by the telomeric protein TRF2
Julien Cherfils-Vicini et al.
EMBO JOURNAL (2019)
Multiple cancer pathways regulate telomere protection
Leire Bejarano et al.
EMBO MOLECULAR MEDICINE (2019)
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Akin Akinc et al.
NATURE NANOTECHNOLOGY (2019)
MiR-182-5p Knockdown Targeting PTEN Inhibits Cell Proliferation and Invasion of Breast Cancer Cells
Yue-Sheng Zhao et al.
YONSEI MEDICAL JOURNAL (2019)
miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a (vol 11, 12, 2018)
Man-Qing Cao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Genome-wide Control of Heterochromatin Replication by the Telomere Capping Protein TRF2
Aaron Mendez-Bermudez et al.
MOLECULAR CELL (2018)
Shelterin-Mediated Telomere Protection
Titia de Lange
ANNUAL REVIEW OF GENETICS, VOL 52 (2018)
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
Jacob O'Brien et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Epigenetic silencing of miR-296 and miR-512 ensures hTERT dependent apoptosis protection and telomere maintenance in basal-type breast cancer cells
Roberto Dinami et al.
ONCOTARGET (2017)
Inhibition of TRF1 Telomere Protein Impairs Tumor Initiation and Progression in Glioblastoma Mouse Models and Patient-Derived Xenografts
Leire Bejarano et al.
CANCER CELL (2017)
A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds
Alejandra Bruna et al.
CELL (2016)
Synthesis and characterization of PEGylated bolaamphiphiles with enhanced retention in liposomes
Yingyue Zhang et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2016)
Patient-derived xenografts: a relevant preclinical model for drug development
Luca Pompili et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer
Cailu Song et al.
SCIENTIFIC REPORTS (2016)
Mir-23a induces telomere dysfunction and cellular senescence by inhibiting TRF2 expression
Zhenhua Luo et al.
AGING CELL (2015)
Therapeutic inhibition of TRF1 impairs the growth of p53-deficient K-RasG12V-induced lung cancer by induction of telomeric DNA damage
Maria Garcia-Beccaria et al.
EMBO MOLECULAR MEDICINE (2015)
MicroRNA-183/182/96 cooperatively regulates the proliferation of colon cancer cells
Qingquan Zhang et al.
MOLECULAR MEDICINE REPORTS (2015)
TRF2 acts as a transcriptional regulator in tumor angiogenesis
Mounir El Mai et al.
MOLECULAR & CELLULAR ONCOLOGY (2015)
miR-155 Drives Telomere Fragility in Human Breast Cancer by Targeting TRF1
Roberto Dinami et al.
CANCER RESEARCH (2014)
Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue - a review
Nickolay Fedchenko et al.
DIAGNOSTIC PATHOLOGY (2014)
In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma
Maria Teresa Di Martino et al.
PLOS ONE (2014)
Transferrin-Conjugated SNALPs Encapsulating 2′-O-Methylated miR-34a for the Treatment of Multiple Myeloma
Immacolata Scognamiglio et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Super-Resolution Fluorescence Imaging of Telomeres Reveals TRF2-Dependent T-loop Formation
Ylli Doksani et al.
CELL (2013)
A two-step mechanism for TRF2-mediated chromosome-end protection
Keiji Okamoto et al.
NATURE (2013)
TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells
Annamaria Biroccio et al.
NATURE CELL BIOLOGY (2013)
MicroRNA 199b-5p delivery through stable nucleic acid lipid particles (SNALPs) in tumorigenic cell lines
Pasqualino de Antonellis et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2013)
The Implications of Clonal Genome Evolution for Cancer Medicine
Samuel Aparicio et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Elevated TRF2 in advanced breast cancers with short telomeres
Malissa C. Diehl et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
The Telomerase Inhibitor Imetelstat Depletes Cancer Stem Cells in Breast and Pancreatic Cancer Cell Lines
Immanual Joseph et al.
CANCER RESEARCH (2010)
Telomere dysfunction promotes genome instability and metastatic potential in a K-ras p53 mouse model of lung cancer
Samanthi A. Perera et al.
CARCINOGENESIS (2008)
Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1
Eros Lazzerini Denchi et al.
NATURE (2007)
Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis
Raquel Blanco et al.
GENES & DEVELOPMENT (2007)
DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion
GB Celli et al.
NATURE CELL BIOLOGY (2005)
Glutathione influences c-Myc-induced apoptosis in M14 human melanoma cells
A Biroccio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer -: Clinical and experimental findings
A Biroccio et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis
E González-Suárez et al.
NATURE GENETICS (2000)
分享论文
